rs2480256 — CYP2E1

CYP2E1 — When the Detox Engine Runs Hot

CYP2E1 (cytochrome P450 2E1) is the liver's chemical-processing workhorse for a surprisingly wide range of exposures: acetaminophen (paracetamol), isoniazid (tuberculosis antibiotic), ethanol at moderate-to-high doses, volatile anesthetics (sevoflurane, isoflurane), and industrial chemicals such as benzene, chloroform, and styrene. The rs2480256 variant in CYP2E1's [3' untranslated region | The 3' UTR is the section of mRNA after the stop codon; it contains binding sites for regulatory microRNAs that control mRNA stability and translation efficiency] acts as a regulatory dial: the A allele increases how much of this enzyme the liver produces. More enzyme means faster processing — but for substrates like acetaminophen, that creates more toxic intermediates, not safer metabolism.

The Mechanism

rs2480256 sits in the 3' UTR of CYP2E1, a region that serves as a docking site for [microRNAs | Small non-coding RNA molecules that bind to the 3' UTR and suppress translation or trigger mRNA degradation] that tune down gene expression. A single nucleotide change at this position can alter or abolish a microRNA binding site, freeing the mRNA from its brakes and allowing the cell to produce more enzyme. Liao et al. (2011)¹¹ Liao et al. (2011)
Liao LH, Zhang H, Lai MP, et al. Single-nucleotide polymorphisms and haplotype of CYP2E1 gene associated with systemic lupus erythematosus in Chinese population. Arthritis Research & Therapy, 2011;13(1):R9. confirmed this transcriptional dose-response in peripheral blood mononuclear cells: cells from A/A homozygotes showed the highest CYP2E1 mRNA levels, followed by A/G heterozygotes, with G/G carriers expressing the least.

For acetaminophen, elevated CYP2E1 activity means more [NAPQI | N-acetyl-p-benzoquinone imine: the reactive, hepatotoxic metabolite generated when CYP2E1 oxidizes acetaminophen; normally neutralized by glutathione, but excess NAPQI depletes GSH and directly damages liver cells] is produced per dose. This toxic intermediate is normally neutralized by glutathione; when NAPQI production outpaces glutathione supply, liver cell injury follows. Chronic ethanol consumption further upregulates CYP2E1 protein and creates a dangerous synergy with acetaminophen — a combination that features prominently in acetaminophen-related acute liver failure cases.

The Evidence

The primary clinical evidence for rs2480256 is an association study in [systemic lupus erythematosus (SLE) | An autoimmune condition driven by immune dysregulation and inflammation; oxidative stress from elevated CYP2E1 may promote the immune activation that underlies SLE] by Liao et al.²² Liao et al.
Liao LH et al. Single-nucleotide polymorphisms and haplotype of CYP2E1 gene associated with systemic lupus erythematosus. Arthritis Res Ther, 2011;13:R9.. In a two-stage case-control design enrolling 876 SLE patients and 680 controls from a Chinese Han population, the A allele was associated with increased SLE risk (OR = 1.165, 95% CI 1.073–1.265, p = 2.75×10⁻⁴). A/A homozygotes showed substantially higher susceptibility (OR = 1.464, 95% CI 1.259–1.702, p = 7.48×10⁻⁷). A combined haplotype analysis with the nearby rs8192772 strengthened the signal. The mechanistic link: CYP2E1 generates [reactive oxygen species | Chemically reactive molecules containing oxygen (superoxide, hydrogen peroxide, hydroxyl radical) that damage DNA, proteins, and lipid membranes; chronic overproduction drives inflammatory and autoimmune processes] as a byproduct of its oxidative reactions; individuals with constitutively higher expression carry greater baseline oxidative burden.

For antitubercular drug toxicity, a 2025 review³³ 2025 review
Bishnu D et al. Unraveling the Role of CYP2E1 in Antitubercular Drug-Induced Hepatotoxicity. Int J Hepatol, 2025. confirmed that CYP2E1 polymorphisms are a significant determinant of individual susceptibility to isoniazid-induced hepatotoxicity, with higher-expressing genotypes converting more isoniazid to hepatotoxic hydrazine intermediates.

Practical Actions

For A/A and A/G individuals, the key concern is acetaminophen safety at high or repeated doses, particularly in the context of alcohol use or fasting. Fasting and ketosis independently upregulate CYP2E1 protein regardless of genotype; an already-elevated baseline combined with acute fasting creates heightened NAPQI generation from even standard acetaminophen doses.

Occupational chemical exposures represent another domain where genotype matters: benzene, chloroform, trichloroethylene, and other industrial solvents are bioactivated by CYP2E1 into more reactive (and more genotoxic) derivatives. Workers in solvent-exposure settings who carry the A allele process more activated metabolite per unit exposure.

Interactions

rs2480256 acts in the same pathway as rs2515641, a synonymous variant in CYP2E1 exon 8 that has the opposite effect: the T allele reduces expression. A carrier of the rs2480256 A allele (higher expression) who also carries the rs2515641 C allele (wild-type expression, no reduction) will have the combined high-expression phenotype. The two variants tag different aspects of CYP2E1 regulation — 3' UTR microRNA-mediated in the case of rs2480256, codon-usage–mediated in the case of rs2515641 — and are not in complete linkage disequilibrium, meaning they can be assessed independently.

Concurrent use of CYP2E1 substrates amplifies risk in A/A carriers: combining acetaminophen with isoniazid, or taking either during heavy alcohol use, creates competitive substrate overload and dramatically increases hepatotoxic intermediate formation. In high-expression A/A individuals, even therapeutic acetaminophen doses combined with alcohol can stress hepatic glutathione reserves.